497 related articles for article (PubMed ID: 19476383)
21. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
[TBL] [Abstract][Full Text] [Related]
22. Inter-oligomer interactions of the human prion protein are modulated by the polymorphism at codon 129.
Gerber R; Voitchovsky K; Mitchel C; Tahiri-Alaoui A; Ryan JF; Hore PJ; James W
J Mol Biol; 2008 Aug; 381(1):212-20. PubMed ID: 18597782
[TBL] [Abstract][Full Text] [Related]
23. The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.
Jun S; Gillespie JR; Shin BK; Saxena S
Biochemistry; 2009 Nov; 48(45):10724-32. PubMed ID: 19824649
[TBL] [Abstract][Full Text] [Related]
24. A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid-like fibrils.
Yang X; Adda CG; Keizer DW; Murphy VJ; Rizkalla MM; Perugini MA; Jackson DC; Anders RF; Norton RS
J Pept Sci; 2007 Dec; 13(12):839-48. PubMed ID: 17883245
[TBL] [Abstract][Full Text] [Related]
25. Structure and morphology of the Alzheimer's amyloid fibril.
Stromer T; Serpell LC
Microsc Res Tech; 2005 Jul; 67(3-4):210-7. PubMed ID: 16103997
[TBL] [Abstract][Full Text] [Related]
26. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.
Jones EM; Surewicz WK
Cell; 2005 Apr; 121(1):63-72. PubMed ID: 15820679
[TBL] [Abstract][Full Text] [Related]
27. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
[TBL] [Abstract][Full Text] [Related]
28. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
29. Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid.
Sciarretta KL; Gordon DJ; Petkova AT; Tycko R; Meredith SC
Biochemistry; 2005 Apr; 44(16):6003-14. PubMed ID: 15835889
[TBL] [Abstract][Full Text] [Related]
30. Distinct morphological and electrophysiological properties of an elk prion peptide.
Glaves JP; Gorski PA; Alier K; Ma L; Renault L; Primeau JO; Jhamandas JH; Young HS
Peptides; 2013 Feb; 40():49-56. PubMed ID: 23262353
[TBL] [Abstract][Full Text] [Related]
31. Helical-ribbon formation by a beta-amino acid modified amyloid beta-peptide fragment.
Castelletto V; Hamley IW; Hule RA; Pochan D
Angew Chem Int Ed Engl; 2009; 48(13):2317-20. PubMed ID: 19222067
[TBL] [Abstract][Full Text] [Related]
32. Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure.
Shewmaker F; Wickner RB; Tycko R
Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19754-9. PubMed ID: 17170131
[TBL] [Abstract][Full Text] [Related]
33. Structural features of proinsulin C-peptide oligomeric and amyloid states.
Lind J; Lindahl E; Perálvarez-Marín A; Holmlund A; Jörnvall H; Mäler L
FEBS J; 2010 Sep; 277(18):3759-68. PubMed ID: 20738396
[TBL] [Abstract][Full Text] [Related]
34. Solid-state NMR structural studies of the fibril form of a mutant mouse prion peptide PrP89-143(P101L).
Lim KH; Nguyen TN; Damo SM; Mazur T; Ball HL; Prusiner SB; Pines A; Wemmer DE
Solid State Nucl Magn Reson; 2006 Feb; 29(1-3):183-90. PubMed ID: 16256316
[TBL] [Abstract][Full Text] [Related]
35. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
Baskakov IV; Bocharova OV
Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
[TBL] [Abstract][Full Text] [Related]
36. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T
J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242
[TBL] [Abstract][Full Text] [Related]
37. The role of hydrophobic interactions in amyloidogenesis: example of prion-related polypeptides.
Tcherkasskaya O; Sanders W; Chynwat V; Davidson EA; Orser CS
J Biomol Struct Dyn; 2003 Dec; 21(3):353-65. PubMed ID: 14616031
[TBL] [Abstract][Full Text] [Related]
38. Molecular alignment within beta-sheets in Abeta(14-23) fibrils: solid-state NMR experiments and theoretical predictions.
Bu Z; Shi Y; Callaway DJ; Tycko R
Biophys J; 2007 Jan; 92(2):594-602. PubMed ID: 17056725
[TBL] [Abstract][Full Text] [Related]
39. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
40. Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways.
Natalello A; Prokorov VV; Tagliavini F; Morbin M; Forloni G; Beeg M; Manzoni C; Colombo L; Gobbi M; Salmona M; Doglia SM
J Mol Biol; 2008 Sep; 381(5):1349-61. PubMed ID: 18619462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
